Jon Emery

MA, MBBCh, MRCGP, FRACGP, DPhil, Director Primary Care Collaborative Cancer Clinical Trials Group (PC4), Herman Professor of Primary Care Cancer Research, Department of General Practice, and Centre for Cancer Research, University of Melbourne, Vic

Chemoprevention: A new concept for cancer prevention in primary care

Prescribing drugs to reduce the risk of cancer is a new development in primary cancer prevention.

‘Why don’t I need a colonoscopy?’ A novel approach to communicating risks and benefits of colorectal cancer screening

Expected frequency trees can be used to promote appropriate patient choice of colorectal cancer screening modality.

Embedding primary healthcare professionals as consumers in cancer research development

It is essential to involve primary healthcare professionals as stakeholders in the development of research questions and study design to ensure relevance and feasibility.

The important role of general practice in the care of cancer survivors

In addition to a role in cancer surveillance, GPs have key roles in the management of comorbid illness, secondary prevention, health promotion, self-management promotion and coordination of care.


Advances in genomic epidemiology and sequencing technology will change the way GPs practice medicine in the 21st century.

Managing patients receiving new and unfamiliar cancer treatments: A qualitative study of general practitioners’ experience

General practitioners’ ability to promptly recognise potentially serious side effects of treatment, especially those unique to newer therapies, can be crucial to patient safety.

Preconception and antenatal carrier screening for genetic conditions: The critical role of general practitioners

General practitioners are ideally placed to offer individuals and couples carrier screening for autosomal recessive and X-linked conditions.

Preparing for the genomics era

The genomics era is finally upon general practice, and we need to be prepared to meet the challenges it raises and reap its benefits.

The CRISP-Q study: Communicating the risks and benefits of colorectal cancer screening

Evidence suggests that GPs and their recommendations consistently improve participation in screening for CRC.